EDSA
Edesa Biotech, Inc.
Edesa Biotech, Inc. (EDSA) has 18 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 2, 2026.
The most active filer is Chief Executive Officer Nijhawan Pardeep with 3 filings.
- Industry:Biotechnology
- CEO:Pardeep Nijhawan
- Employees:16
- HQ:Markham, ON, CA
- IPO:2010-06-21
Insider Buying
$89K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$47.7M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Brooks Michael JFirst filing | President | Purchase | 2,000 | $3K | Mar 11 | SEC ↗ |
| Chief Executive Officer | Purchase | 1,000 | $7K | Mar 10 | SEC ↗ | |
| Chief Executive Officer | Purchase | 10,000 | $43K | Mar 5 | SEC ↗ | |
Nijhawan PardeepFirst filing | Chief Executive Officer | Purchase | 10,000 | $36K | Mar 4 | SEC ↗ |
Related companies
Edesa Biotech, Inc. is in the Healthcare sector.